Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 17/20 | 0.38 |
| ▸ | KLK1 | P06870 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1384406 | 0.94 | KCNH2 (0.45) | KCNH2F10KLK1 | |
| SCHEMBL1386783 | 0.90 | KCNH2 (0.40) | KCNH2F10ACACB | |
| SCHEMBL1385845 | 0.89 | KCNH2 (0.46) | KCNH2F10KLK1ACACB | |
| SCHEMBL1385672 | 0.87 | F10 (0.41) | KCNH2F10ACACBHTR7HTR6 | |
| SCHEMBL1385080 | 0.84 | KCNH2 (0.45) | KCNH2F10 | |
| SCHEMBL1385994 | 0.84 | F10 (0.44) | F10 | |
| SCHEMBL1386823 | 0.83 | KCNH2 (0.52) | KCNH2F10KLK1 | |
| SCHEMBL1385505 | 0.79 | F10 (0.39) | KCNH2F10ACACB | |
| SCHEMBL4397700 | 0.79 | F10 (0.39) | KCNH2F10ACACB | |
| SCHEMBL1384724 | 0.77 | KCNH2 (0.39) | KCNH2F10ACACB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4829449-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| JP-2003508353-A | — | — | 2003-03-04 | — | — | JP | claimed |
| EP-1208097-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | Aventis Pharmaceuticals Inc. (US) | 2002-05-29 | — | — | EP | claimed |
| WO-2001007436-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-02-01 | — | — | WO | claimed |
| US-7612075-B2 | Substituted oxoazaheterocyclyl compounds | AVENTIS PHARMACEUTICALS INC. (US) | 2009-11-03 | — | — | US | disclosed |